AstraZeneca’s Trixeo Aerosphere has been recommended for approval in the [...]

The EMA’s CHMP has recommended marketing authorisation for two obicetrapib [...]

The EMA’s CHMP has recommended EU approval of Lynavoy for [...]

The EMA’s CHMP has recommended approval of NEZGLYAL for boys [...]

Atsena Therapeutics has received EMA orphan designation for two gene [...]

The European Medicines Agency (EMA) has accepted Almirall’s application to [...]

AstraZeneca and Amgen’s Tezspire (tezepelumab) has received a positive opinion [...]

As global pharma grapples with shifting regulations, rising geopolitical tensions, [...]